Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Stealth BioTherapeutics Announces Positive Results for Elamipretide in Barth Syndrome Open-Label Extension Trial

americanpharmaceuticalreviewApril 18, 2019

Tag: Stealth BioTherapeutics , Barth Syndrome , elamipretide

PharmaSources Customer Service